Experimental Vaccine Aims to Prevent Fentanyl Overdose
實驗性疫苗旨在預防芬太尼過量
更新於: 2026年6月14日 上午01:30
As the opioid crisis persists, researchers are developing a proactive weapon: an experimental vaccine for fentanyl.
隨著鴉片類藥物危機持續蔓延，研究人員正在開發一種前瞻性的武器：一種芬太尼實驗性疫苗。
Unlike naloxone, which is used to reverse an overdose after it begins, these vaccines are designed to prevent the drug from ever reaching the brain.
不同於用於在過量使用後進行逆轉的納洛酮，這些疫苗旨在阻止藥物到達大腦。
The vaccine trains the immune system to create antibodies that bind to fentanyl in the bloodstream.
疫苗能訓練免疫系統製造出抗體，與血液中的芬太尼結合。
This creates a complex too large to cross the blood-brain barrier, effectively neutralizing the drug before it can cause a high or respiratory suppression.
這會形成一個過大而無法穿過血腦屏障的複合體，在藥物引發欣快感或呼吸抑制之前有效將其阻斷。
A major breakthrough from Scripps Research in 2026 involves a vaccine candidate that can recognize a wide range of fentanyl variants, keeping pace with illicit drug modifications.
Scripps Research 於 2026 年取得的一項重大突破，在於開發出一種能識別多種芬太尼變體的候選疫苗，以跟上非法藥物變異的步伐。
While human trials are slated to begin shortly, experts stress that this is not a 'cure' for addiction.
儘管人體試驗即將展開，專家仍強調這並非成癮的「治療良方」。
By preventing the euphoric effects of the drug, the vaccine acts as a relapse-prevention tool and a safety net for those at risk of accidental exposure, intended to work alongside existing treatments and recovery services.
藉由預防藥物帶來的欣快感，疫苗能作為防止復發的工具，並為意外暴露於藥物風險中的族群提供安全網，旨在與現有的治療和復健服務相輔相成。
